Publication:
Bioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)

dc.contributor.authorSarassawan Kananuraksen_US
dc.contributor.authorMontira Assanathamen_US
dc.contributor.authorSarinya Boongirden_US
dc.contributor.authorChagriya Kitiyakaraen_US
dc.contributor.authorKanin Thammavaranucupten_US
dc.contributor.authorThosaphol Limpijarnkijen_US
dc.contributor.authorDaruneewan Warodomwichiten_US
dc.contributor.authorAndrew Davenporten_US
dc.contributor.authorArkom Nongnuchen_US
dc.contributor.otherUniversity College Londonen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.date.accessioned2020-08-25T11:21:06Z
dc.date.available2020-08-25T11:21:06Z
dc.date.issued2020-01-01en_US
dc.description.abstract© 2020 International Society of Nephrology Introduction: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administration protocol guided by measuring extracellular water (ECW) using bioimpedance analysis (BIA) would be safe and would reduce the incidence CI-AKI compared to a standardized fluid administration prescription. Methods: In this pilot, randomized, parallel-group, single-blind, controlled trial, we compared the effect of BIA-guided isotonic bicarbonate administration according to the ratio of ECW to total body water (ECW/TBW) to our standard isotonic bicarbonate protocol in regard to the safety and efficacy of preventing CI-AKI in chronic kidney disease patients undergoing elective cardiac angiography. Our primary outcome was the incidence of CI-AKI, which was defined as a ≥0.3 mg/dl or 150% increase in serum creatinine concentration within 48 to 72 hours after cardiac angiography. Results: We studied 61 patients, 30 in the bioimpedance group and 31 in the control group. Age was similar (72.5 ± 7 vs. 71.4 ± 7.9 years), as were body mass index (25.5 vs. 25.8 kg/m2) and baseline serum creatinine (1.3 ± 0.3 vs. 1.4 ± 0.4 mg/dl). The peri-procedural fluid volume administered was significantly greater in the BIA-guided hydration group (899.0 ± 252.7 ml vs. 594.4 ± 125.9 ml, P <.01). The incidence of CI-AKI was 3.3% in BIA-guided hydration group and 6.5% in the control group (relative risk = 0.52, 95% confidence interval = 0.05−5.40, P = 1.00). Adverse events reported were comparable between groups (6.7% vs. 6.5%, P = 1.00). Conclusions: The overall incidence of CI-AKI after cardiac angiography in our patients with mild-to-moderate renal insufficiency was lower than anticipated. Isotonic bicarbonate administration guided by bioimpedance measurements was safe, and probably led to a lower incidence of CI-AKI, although this not reach statistical significance.en_US
dc.identifier.citationKidney International Reports. (2020)en_US
dc.identifier.doi10.1016/j.ekir.2020.07.009en_US
dc.identifier.issn24680249en_US
dc.identifier.other2-s2.0-85089297563en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/58296
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089297563&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleBioimpedance Analysis–Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial)en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089297563&origin=inwarden_US

Files

Collections